Dysregulation of DUSP22 in T cells contributes to the development of several human diseases7, including peripheral T-cell lymphoma8, inflammatory bowel disease (IBD)9, systemic lupus erythematosus (SLE)10, and ankylosing spondylitis (AS)11. Here, DUSP22 is linked to systemic lupus erythematosus.